web-based data entry tool endoacro (Pfizer Inc)
90
Structured Review
Pfizer Inc
web-based data entry tool endoacro
Web Based Data Entry Tool Endoacro, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/web-based+data+entry+tool+endoacro/web+based+data+entry+tool+endoacro/pm25916431-26-7-16
Average 90 stars, based on 1 article reviews
Web Based Data Entry Tool Endoacro, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/web-based+data+entry+tool+endoacro/web+based+data+entry+tool+endoacro/pm25916431-26-7-16
Average 90 stars, based on 1 article reviews
web-based data entry tool endoacro - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Does pegvisomant treatment expertise improve control of resistant acromegaly? The Italian ACROSTUDY experience. Article Snippet: uncontrolled patients than in controlled ones only in group A.. Reported adverse events were more frequent, and the prevalence of patients with adverse events was higher in group B.. Conclusions On the basis of this original study approach, we could speculate that in the centers in which more patients are treated with pegvisomant, less adverse events are reported, but the long-term effectiveness is lower than in centers with less cases, perhaps because of an inadequate patient’s selection. |